OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLI1: A Therapeutic Target for Cancer
Justin Avery, Ruowen Zhang, Rebecca J. Boohaker
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Ngoc Minh Nguyen, Jungsook Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1733-1733
Open Access | Times Cited: 86

Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 2

New Insight into the Effects of Metformin on Diabetic Retinopathy, Aging and Cancer: Nonapoptotic Cell Death, Immunosuppression, and Effects beyond the AMPK Pathway
Sheng‐Kai Hsu, Kai‐Chun Cheng, Miracle Oluebube Mgbeahuruike, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9453-9453
Open Access | Times Cited: 58

Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
Fangzhou He, Jiuhui Xu, Fanwei Zeng, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Lobaric acid suppresses the stemness potential of colorectal cancer cells through mTOR/AKT
Sultan Pulat, Jaycee Augusto Gumiran Paguiri, Chathurika D. B. Gamage, et al.
BioFactors (2025) Vol. 51, Iss. 1
Closed Access | Times Cited: 1

Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention
Beena Thazhackavayal Baby, Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 754, pp. 109952-109952
Open Access | Times Cited: 6

Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou, Fan Zhou, Shujing Xu, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 799-813
Closed Access | Times Cited: 6

CK2 and the Hallmarks of Cancer
May-Britt Firnau, Angela Brieger
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1987-1987
Open Access | Times Cited: 27

Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth
Luisa Maresca, Enrica Crivaro, Francesca Migliorini, et al.
Pharmacological Research (2023) Vol. 195, pp. 106858-106858
Open Access | Times Cited: 16

The role of KLF transcription factor in the regulation of cancer progression
Ziyi Li, Yuxin Zhu, Jian-Rui Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114661-114661
Open Access | Times Cited: 15

Hedgehog Pathway Inhibitors against Tumor Microenvironment
Silpa Gampala, Jer‐Yen Yang
Cells (2021) Vol. 10, Iss. 11, pp. 3135-3135
Open Access | Times Cited: 30

GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis
Darcy A. Kerr, Jeffrey M. Cloutier, Matthew Margolis, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100386-100386
Closed Access | Times Cited: 12

EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15173-15173
Open Access | Times Cited: 11

The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms
Isidro Machado, Abbas Agaimy, Francisco Giner, et al.
Virchows Archiv (2023) Vol. 484, Iss. 5, pp. 765-775
Closed Access | Times Cited: 11

Landscape of human protein-coding somatic mutations across tissues and individuals
Huixin Xu, Rob Bierman, Dayna T. Akey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
Ronaldo Paolo Panganiban, Christina McAninch, Marina Chulkina, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access

GLI1-Rearranged Enteric Tumors: Updates on Clinicopathologic and Molecular Genetics Features
Ahmed I. Younes, Haider A. Mejbel
Cells (2025) Vol. 14, Iss. 2, pp. 118-118
Open Access

Breast cancer stem cell: Role in pathogenesis
Riya Sharma, Vikas Tiwari, Seema Seema, et al.
Elsevier eBooks (2025), pp. 207-224
Closed Access

USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression
Shaoxuan Cheng, Zhiyuan Qiu, Ziyi Zhang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

Epithelial-mesenchymal transition in cancer: A focus on itraconazole, a hedgehog inhibitor
Aniruddha Murahar Kulkarni, Prasanna Kumar Reddy Gayam, Beena Thazhackavayal Baby, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189279-189279
Open Access

Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers
Radhika Gutta, Emily A. Teslow, Ellen B. Jaeger, et al.
Clinical Lung Cancer (2025)
Closed Access

Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation
Benjamin I. Siegel, Prabhumallikarjun Patil, Annapoorna Prakash, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Novel C-2 Aromatic Heterocycle-Substituted Triterpenoids Inhibit Hedgehog Signaling in GLI1 Overexpression Cancer Cells
Ivo Frydrych, Barbora Choma, Lenka Slavíková, et al.
ACS Omega (2025) Vol. 10, Iss. 10, pp. 10617-10632
Open Access

FBXO32 ubiquitination of SUFU promotes progression and lenvatinib resistance in hepatocellular carcinoma via hedgehog signaling
Shunyi Wang, Rui Peng, Chen Chen, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

Page 1 - Next Page

Scroll to top